Las Vegas, NV -- (SBWIRE) -- 01/16/2014 -- EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more .EquityObserver.com issues a special report on the following stocks: DURECT Corporation(NASDAQ:DRRX), Inovio Pharmaceuticals Inc(NYSEMKT:INO), LDK Solar Co., Ltd (ADR)(NYSE:LDK), Zogenix, Inc.(NASDAQ:ZGNX)
DURECT Corporation(NASDAQ:DRRX) was a volume gainer of 2.44 million shares and the average volume of the stock remained 814,289.00 shares. The stock opened the session at $2.07 and finished at the end of the day at $2.04 and the stock plunged -0.97%.The market capitalization of the stock remained 224.94 million. DURECT Corporation, a specialty pharmaceutical company, develops pharmaceutical systems technologies based on its proprietary drug delivery technology platforms. The company was founded in 1998 and is headquartered in Cupertino, California.
Has DRRX Found The Bottom And Ready To Gain Momentum? Find Out Here
In the preceding trading session, Inovio Pharmaceuticals Inc(NYSEMKT:INO) exchanged 2.42 million shares and the average volume remained 5.50 million shares. The stock closed the session at $2.44 with the drop of -0.41%. Inovio Pharmaceuticals, Inc., together with its subsidiaries, engages in the discovery and development of synthetic vaccines and immune therapies focusing on cancers and infectious diseases. Inovio Pharmaceuticals, Inc. was founded in 1983 and is headquartered in Blue Bell, Pennsylvania.
Why Should Investors Buy INO After the Recent Fall? Just Go Here and Find Out
LDK Solar Co., Ltd (ADR)(NYSE:LDK) decreased -4.51% and its closing price was $1.27. The volume of the stock was 2.40 million shares and the average volume remained 1.16 million shares. The market capitalization of the stock remained 201.71 million. The beta of the stock remained 3.06. LDK Solar Co., Ltd., together with its subsidiaries, engages in the design, development, manufacture, and marketing of photovoltaic (PV) products; and development of power plant projects in the People?s Republic of China and internationally.
Will LDK Get Buyers Even After The Recent Rally? Find Out Here
Zogenix, Inc.(NASDAQ:ZGNX) exchanged 2.34 million shares in the previous trading session, and its average trading remained 2.58 million shares. ZGNX dropped -0.68% and it closed the trading at $4.39. The market capitalization of the stock remained 607.72 million. Zogenix, Inc., a pharmaceutical company, engages in the development and commercialization of products for the treatment of central nervous system disorders and pain. Zogenix, Inc. was founded in 2006 and is headquartered in San Diego, California.
Has ZGNX Found The Bottom and Ready To Move Up? Find Out Here
About Equity Observer:
Equity Observer delivers intra-day insights into the equities, tech and investment world. The website is a window into what’s going on in the business world and why.
EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more.
The disclaimer is to be read and fully understood before using our site, or joining our email list.
http://www.equityobserver.com/ has a no tolerance spam policy; we will not sell or re-distribute your email to any 3rd party. A If applicable, please also unsubscribe from the newsletter using the link at the bottom of the email if you no longer wish to receive our emails. We only send our newsletters to opt-in members.
PLEASE NOTE WELL: The http://www.equityobserver.com/" rel="nofollow" href="http://www.equityobserver.com/"> http://www.equityobserver.com/>
Employees and contributors are NOT registered as an Investment Adviser in any jurisdiction whatsoever.
Read Full Disclaimerat: http://www.equityobserver.com/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)